logo

For the Inventor, By the Inventor

Redhill, United Kingdom

Keith H Baggaley

USPTO Granted Patents = 19

Average Co-Inventor Count = 1.8

ph-index = 6

Forward Citations = 151(Granted Patents)


Location History:

  • Redhill, EN (1976 - 1978)
  • Betchworth, GB (1989 - 1992)
  • Redhill, GB (1978 - 1999)

Company Filing History:

goldMedal18 out of 855 
 
Beecham Group Plc
 patents
silverMedal1 out of 2,198 
 
Smithkline Beecham Corporation
 patents

Years Active: 1976-1999

Loading Chart...
19 patents (USPTO):Explore Patents
1. 5869299 - Process for producing clavulanic acid (1999-02-09),
2. 5130241 - Clavam derivatives and its enzymatic preparation (1992-07-14),
3. 4795809 - Novel clavam derivatives and methods of making same (1989-01-03),
4. 4362892 - Hypolipidaemic compounds (1982-12-07),
5. 4350702 - Method of inhibiting platelet aggregation (1982-09-21),
6. 4341708 - Prostacyclin aza analogue intermediates (1982-07-27),
7. 4262008 - 2,4-Disubstituted 5-oxo-5H-hexahydrofuro[3,2b]pyrroles (1981-04-14),
8. 4243669 - 2-Substituted benzisothiazolones (1981-01-06),
9. 4212979 - 2-Substituted benzisothiazolones (1980-07-15),
10. 4212872 - 2-Substituted benzisothiazolones and use thereof (1980-07-15),
11. 4206145 - Hypolipidaemic compounds and compositions (1980-06-03),
12. 4186203 - 2-[Gamma-(1-piperidinyl)propyl]-1,2-benzisothiazole-3-one, its salts, (1980-01-29),
13. 4182768 - Prophylaxis or treatment of thromboses and inhibition of platelet (1980-01-08),
14. 4154850 - Certain di-(substituted phenoxy) alkanes and hypolipidaemic use thereof (1979-05-15),
15. 4113728 - 2-Substituted benzisothiazolones (1978-09-12),

Title: The Innovative Path of Inventor Keith H Baggaley

Introduction

Keith H Baggaley, an accomplished inventor based in Redhill, GB, has made significant contributions to the field of biochemistry and pharmaceuticals. With a remarkable portfolio that includes 19 patents, Baggaley's innovative spirit has been instrumental in advancing scientific knowledge and industry practices.

Latest Patents

Among his latest patents, Baggaley has developed a process for producing clavulanic acid and its derivatives. This patent describes a compound having a specific formula, alongside its salts, and introduces an enzymatic process for converting such compounds into clavulanic acid. Notably, this process utilizes a novel enzyme system derived from microorganisms, particularly a species of Streptomyces, to achieve the desired cyclization. His work in this area showcases his dedication to enhancing pharmaceutical products and methods.

Career Highlights

Throughout his career, Keith H Baggaley has collaborated with prominent organizations in the pharmaceutical sector. He has worked with Beecham Group Plc and SmithKline Beecham Corporation, where his innovative ideas and expertise have contributed to significant advancements in drug development and production processes.

Collaborations

During his professional journey, Baggaley has teamed up with notable colleagues, including Brian Morgan and Richard M Hindley. These collaborations have played a crucial role in his success, fostering an environment of creativity and shared knowledge that drives innovation forward.

Conclusion

In summary, Keith H Baggaley's exceptional contributions to the field of pharmaceuticals through his inventions and patents reflect his remarkable talent and dedication. His groundbreaking work continues to influence the industry, inspiring future innovations and paving the way for new discoveries in biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…